Authors:
JERJIS S
ROOVERS E
MUUS P
SCHAAP N
DEWITTE T
Citation: S. Jerjis et al., IDARUBICIN TO INTENSIFY THE CONDITIONING REGIMENS OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION, Bone marrow transplantation, 22(1), 1998, pp. 13-19
Authors:
SCHATTENBERG A
PREIJERS F
SCHAAP N
DEWITTE T
Citation: A. Schattenberg et al., COMPARISON OF ALLOGENEIC BLOOD AND MARROW TRANSPLANTATION WITH GRAFTSDEPLETED OF LYMPHOCYTES USING COUNTERFLOW CENTRIFUGATION, Bone marrow transplantation, 21, 1998, pp. 141-141
Authors:
SCHAAP N
SCHATTENBERG A
BAR B
MENSINK E
DEMAN A
DEWITTE T
Citation: N. Schaap et al., SEQUENTIAL-ANALYSIS OF CHIMERISM USING RED-BLOOD-CELL PHENOTYPING IS STRONGLY CORRELATED WITH HEMATOLOGIC, CYTOGENETIC AND QUANTITATIVE MOLECULAR RESPONSE AFTER DONOR LEUKOCYTE INFUSIONS FOR RELAPSED CHRONIC MYELOID-LEUKEMIA, Bone marrow transplantation, 21, 1998, pp. 237-237
Authors:
SCHATTENBERG A
SCHAAP N
VANDEWIELVANKEMENADE E
BAR B
ROOVERS E
PREIJERS F
DEWITTE T
Citation: A. Schattenberg et al., OUTCOME OF DONOR LEUKOCYTE INFUSION (DLI) FOR RELAPSE AFTER BMT IS DEPENDENT ON THE INDICATION FOR TRANSPLANTATION AND CHIMERISM OF T-LYMPHOCYTES, Bone marrow transplantation, 21, 1998, pp. 241-241
Authors:
SCHAAP N
SCHATTENBERG A
HILLEGERS M
KNOPS R
PENNINGS A
DEWITTE T
Citation: N. Schaap et al., CHIMERISM PATTERNS IN SUBPOPULATIONS OF PBMCS IN STABLE MIXED CHIMERAS CHIMERAS AFTER T-CELL DEPLETED BMT, Bone marrow transplantation, 21, 1998, pp. 259-259
Authors:
JERJIS S
ROOVERS E
MUUS P
SCHAAP N
DEWITTE T
Citation: S. Jerjis et al., IDARUBICIN TO INTENSIFY THE CONDITIONING REGIMENS OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION, Bone marrow transplantation, 21, 1998, pp. 350-350
Authors:
JERJIS S
CROOCKEWIT S
ROOVERS E
PREIJERS F
SCHAAP N
MUUS P
DEWITTE T
Citation: S. Jerjis et al., COST-ANALYSIS OF AUTOLOGOUS PERIPHERAL STEM-CELL TRANSPLANTATION VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN LYMPHOPROLIFERATIVE MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 685-685
Authors:
MENSINK E
VANDELOCHT A
SCHATTENBERG A
LINDERS E
SCHAAP N
VANKESSEL AG
DEWITTE T
Citation: E. Mensink et al., QUANTITATION OF MINIMAL RESIDUAL DISEASE IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA PATIENTS USING REAL-TIME QUANTITATIVERT-PCR, British Journal of Haematology, 102(3), 1998, pp. 768-774
Authors:
SCHAAP N
SCHATTENBERG A
BAR B
PREIJERS F
DEWITTE T
Citation: N. Schaap et al., PREVENTION OF RELAPSE AFTER LYMPHOCYTE DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION BY PREEMPTIVE DONOR LEUKOCYTE INFUSIONS IN PATIENTS WITH HIGH-RISK OF RELAPSE, British Journal of Haematology, 102(1), 1998, pp. 12-12
Authors:
MATTIJSSEN V
SCHATTENBERG A
SCHAAP N
PREIJERS F
DEWITTE T
Citation: V. Mattijssen et al., OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH LYMPHOCYTE-DEPLETED MARROW GRAFTS IN ADULT PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Bone marrow transplantation, 19(8), 1997, pp. 791-794
Authors:
SCHATTENBERG A
PREIJERS F
MENSINK E
BAR B
SCHAAP N
VANKESSEL AG
VANDERMAAZEN R
DEWITTE T
Citation: A. Schattenberg et al., SURVIVAL IN FIRST OR 2ND REMISSION AFTER LYMPHOCYTE-DEPLETED TRANSPLANTATION FOR PHILADELPHIA-CHROMOSOME-POSITIVE CML IN FIRST CHRONIC PHASE, Bone marrow transplantation, 19(12), 1997, pp. 1205-1212
Authors:
SCHAAP N
SCHATTENBERG A
BAR B
PREIJERS F
VANKESSEL AG
VANDERMAAZEN R
DEBOO T
DEWITTE T
Citation: N. Schaap et al., OUTCOME OF TRANSPLANTATION FOR STANDARD-RISK LEUKEMIA WITH GRAFTS DEPLETED OF LYMPHOCYTES AFTER CONDITIONING WITH AN INTENSIFIED REGIMEN, British Journal of Haematology, 98(3), 1997, pp. 750-759
Authors:
SCHAAP N
RAYMAKERS R
SCHATTENBERG A
OTTEVANGER JP
DEWITTE T
Citation: N. Schaap et al., MASSIVE PLEURAL EFFUSION ATTRIBUTED TO HIGH-DOSE CYCLOPHOSPHAMIDE DURING CONDITIONING FOR BMT, Bone marrow transplantation, 18(1), 1996, pp. 247-248